Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma

被引：0
|
作者：
Le Ngoc Ha
Amir Iravani
Nguyen Thi Nhung
Ngo Thi Minh Hanh
Febby Hutomo
Mai Hong Son
机构：
[1] 108 Central Military Hospital,Department of Nuclear Medicine
[2] Washington University School of Medicine,Department of Pathology
[3] Mallinckrodt Institute of Radiology,Nuclear Medicine Department
[4] 108 Central Military Hospital,undefined
[5] MRCCC Siloam Hospital,undefined
来源：
Cancer Imaging | / 21卷
关键词：
F-fluorodeoxyglucose; BRAF ; mutation; Histopathologic type; Radioiodine-refractory; Differentiated thyroid carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
    Le Ngoc Ha
    Iravani, Amir
    Nguyen Thi Nhung
    Ngo Thi Minh Hanh
    Hutomo, Febby
    Mai Hong Son
    [J]. CANCER IMAGING, 2021, 21 (01)
  • [2] Impact of FDG-PET/CT in patients with radioiodine-negative differentiated thyroid carcinoma
    Mustafa, Mona
    Ilhan, Harun
    Haug, Alexander
    Bartenstein, Peter
    Rominger, Axel
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [3] FDG avidity of metastatic differentiated thyroid cancer is superior to radioiodine avidity in prediction of radioactive iodine therapy response.
    Kang, Seo Young
    Bang, Ji In
    Suh, Min Seok
    Chung, June-Key
    Lee, Dong Soo
    Kang, Keon Wook
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [4] Preoperative diagnostic value [18F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma
    Frilling, A
    Tecklenborg, K
    Görges, R
    Weber, F
    Clausen, M
    Broelsch, EC
    [J]. ANNALS OF SURGERY, 2001, 234 (06) : 804 - 811
  • [5] Distant metastatic lesions in patients with differentiated thyroid carcinoma Clinical implications of radioiodine and FDG uptake
    Hong, C. M.
    Ahn, B. -C.
    Jeong, S. Y.
    Lee, S. -W.
    Lee, J.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (04): : 121 - 129
  • [6] Contrast-Enhanced 18F-FDG PET/CT in Detection of Recurrent/Metastatic Radioiodine Negative Differentiated Thyroid Carcinomas
    Koranda, P.
    Polzerova, H.
    Quinn, L.
    Buriankova, E.
    Formanek, R.
    Halenka, M.
    Mocnakova, M.
    Kaminek, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S142 - S143
  • [7] Preoperative diagnostic value [18F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma -: Discussion
    Hamberger, B
    Farndon, J
    Frilling, A
    [J]. ANNALS OF SURGERY, 2001, 234 (06) : 811 - 811
  • [8] Survival and prognostic factors of radioiodine refractory pulmonary metastatic differentiated thyroid carcinoma (DTC).
    Wassermann, Johanna
    Bernier, Marie-Odile
    Spano, Jean-Philippe
    Lepoutre-Lussey, Charlotte
    Simon, Jean-Marc
    Menegaux, Fabrice
    Hoang, Catherine
    Aurengo, Andre
    Leenhardt, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Results of Rosiglitazone Therapy in Patients with Thyroglobulin-Positive and Radioiodine-Negative Advanced Differentiated Thyroid Cancer
    Kebebew, Electron
    Lindsay, Sheila
    Clark, Orlo H.
    Woeber, Kenneth A.
    Hawkins, Randall
    Greenspan, Francis S.
    [J]. THYROID, 2009, 19 (09) : 953 - 956
  • [10] Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
    Dong, Meng-Jie
    Liu, Zhen-Feng
    Zhao, Kui
    Ruan, Ling-Xiang
    Wang, Guo-Lin
    Yang, Shu-Ye
    Sun, Fang
    Luo, Xu-Guang
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (08) : 639 - 650
12345